Company ProfilePremium

AKI India Limited

Company Profile Analysis

Tickers: AKI.NS, 542020.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
AKI India Limited - Company showcase

Year Founded & Workforce

1994

16 Employees

AKI India Limited logo

AKI India Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

AKI India Limited Overview

AKI India Limited is a Kanpur-based, family-promoted manufacturer and exporter of genuine leather and leather products whose origins lie in equestrian saddlery and harness goods made with technical assistance from a German horse-riding group. Over three decades it has layered on leather footwear (from 2007–08), an owned tannery at Unnao (acquired around 2010) producing finished and upholstery leather, leather accessories, pet accessories and trading in leather chemicals. The company is vertically integrated from hide to finished product but sub-scale: FY2026 consolidated revenue was INR 107.3 Cr. Its strategic pivot since 2023 has been to move closer to Western end-customers through a wholly owned UK subsidiary (AKI UK Limited) and an equity-accounted footwear joint venture (AKI Castil Shoes LLP, understood to be the vehicle for the announced partnership with UK bootmaker NPS Shoes, owner of the Solovair brand). Operating margins at the core business are currently negative; reported profit depends on other income and associate earnings.


Company's own description

The company's website and annual-report language describe AKI India as an ISO-certified public limited company primarily engaged in the design and manufacture of leather products for equestrian sports, horse covers (rugs), leather shoes, bags, belts, pet accessories, and all types of finished leather, with an emphasis on quality and craftsmanship in both domestic and international markets. Corporate regulatory filings describe the company as "primarily engaged in the business of manufacturing and trading of Leather and Leather Goods" and state that it operates in a single primary segment, Leather & Leather Goods, so Ind AS 108 segment reporting is not applied. The MCA classifies its main line of business as tanning and dressing of leather and manufacture of luggage, handbags, saddlery, harness and footwear.

The company's mission statement (website) emphasises premium quality, a blend of traditional technique and innovation, sustainability and ethical practices, and long-term customer relationships; its vision is to become a global leader in leather known for quality, design and sustainable practice.

Independent characterisation

AKI India is best understood as a small, export-oriented, vertically integrated leather converter with four economic engines:

  1. Tannery (Unnao): Processes raw hides into finished leather and upholstery leather — both for captive consumption and for third-party sale. This is the base of the integration and the main source of the LWG Gold rating. Finished-leather sales are commodity-like and price-sensitive.

  2. Equestrian and saddlery products (heritage line): Bridles, browbands, crown pieces, reins, head collars, halters, chaps and gaiters, saddle girths, driving harness, pony articles and horse rugs. These are low-volume, labour-intensive, design-led products sold predominantly to European, Australian and other equestrian markets, typically on a private-label or OEM basis.

  3. Footwear: Formal, riding, deck/marine, casual and canvas shoes, countryside boots, and sandals/slippers. Historically export OEM; since 2023–24 the company has sought a branded/premium angle through the NPS Shoes (Solovair) partnership and a UK sales presence.

  4. Accessories, pet products and trading: Leather bags, belts, wallets, dog collars, leads and covers, dog toys; plus domestic trading in leather chemicals and purchased stock-in-trade.

Business and revenue model

DimensionAssessment
Product vs. service vs. subscription vs. licensing mixEssentially 100% product sales (manufactured goods plus traded goods). No subscription or licensing revenue disclosed. "Other income" (INR 10.94 Cr in FY2026, consolidated) is material relative to operating profit — its composition (export incentives, interest, forex gains, etc.) is not itemised in the sources reviewed.
Manufactured vs. tradedFY2026 standalone: cost of materials consumed INR 46.87 Cr; purchases of stock-in-trade INR 13.41 Cr, against standalone net sales of INR 64.71 Cr — indicating that roughly one-fifth of standalone sales by cost basis are traded goods.
ChannelPredominantly B2B: private-label/OEM supply to overseas importers, brand owners and wholesalers; intra-group sales to AKI UK Limited and AKI Castil Shoes LLP; domestic sales of finished leather and leather chemicals. The company had a retail foray from 2013 (branded basic footwear wholesale/distribution); current scale of retail is not disclosed.
Customer typesOverseas importers/distributors of equestrian goods and footwear; brand owners; bulk buyers and medium-scale wholesalers (per company marketplace listings); domestic tanneries/manufacturers (chemicals and finished leather). Named customers: not publicly disclosed.
End-marketsEquestrian sports and leisure riding; men's and women's leather footwear (formal, outdoor, country, marine); fashion accessories; pet accessories; upholstery leather (furniture/automotive end-use not specified).
Geographic marketsIndia, Europe (UK prominent), Australia, UAE and South Africa (company statement, October 2023). Exports were INR 37.81 Cr of FY2025 standalone revenue.
Value-chain positionMid-stream to downstream: raw hide → finished leather (owned tannery) → finished goods (own factories) → wholesale/B2B. Does not own consumer brands of scale; branding ambitions run through the NPS/Solovair JV and the UK subsidiary.
Working-capital intensityVery high. Cash conversion cycle widened from 114 days (FY2023) to 214 days (FY2026), driven by inventory days of 210 (Screener.in, consolidated).

Strategy

Stated strategy

AKI India does not publish an investor-day presentation or medium-term targets. Its stated strategic themes, drawn from the website mission/vision, FY2025 Board's Report summaries and management statements around the October 2023 fundraise, are:

  1. Premiumisation and quality leadership — combining traditional craftsmanship with modern methods; LWG Gold and ISO certifications as differentiators.

  2. Sustainability and ethical production — "green initiative," LWG Gold rating, and a stated FY2025 focus on sustainable leather production.

  3. Market expansion — broadening international reach, particularly the UK/Europe.

  4. Inflection-point capital raising — the founder characterised the company as at an "inflexion point" in October 2023 and positioned the INR 80 Cr fundraise as the means to reach a new scale.

  5. Partnership-led branded growth — the NPS Shoes JV to bring Solovair to India and co-manufacture/export.

Initiatives in the last 24 months (Oct 2024 – Oct 2026)

InitiativeDateDescriptionStatus
Warrant conversion (INR 80 Cr programme, second leg)May–Jun 2025Second and third tranches of consideration received (15 and 24 May 2025); 1,46,73,782 of 1,74,41,782 warrants converted on 9 Jun 2025Completed for 84% of warrants; status of remaining 27,68,000 warrants not disclosed (likely lapsed after 18-month window)
AKI Castil Shoes LLP ramp-upFY2025–FY2027Footwear JV at Unnao; share of associate profit rose to INR 0.45 Cr in Q1 FY2027 from INR 0.02 CrOperating; scale undisclosed
AKI UK Limited scale-upFY2026–FY2027Material RPT envelope of ≈INR 30 Cr with AKI UK approved by board (1 Sep 2026) and AGM (23 Sep 2026)Ongoing
Governance reconstitutionJan–Jul 2026Three board/committee reconstitutions; internal auditor appointed for FY2027Completed (see Section 9)
Capacity expansionFY2025Board's Report summaries cite expanded capacity and improved inventory management; CWIP INR 10 Cr at Mar 2026Not quantified
SustainabilityOngoingLWG Gold; ISO 14001; CSR and green-initiative pagesOngoing

Cost programmes / transformation programmes with targets: None disclosed.

Management guidance

No quantitative guidance (revenue, margin or capex) has been issued. There are no earnings calls. Consensus estimates do not exist.

Products & Services

The company's website organises products under six main categories. No pricing, launch dates or volumes are disclosed for any product; the company sells predominantly on a made-to-order/OEM basis with customisation capability.

Equestrian Products (heritage line, since 1994)

ProductDescription / capabilitiesTarget customerPricing model
BridlesLeather headgear for horse control; English-style designsEquestrian importers, tack shops (Europe, Australia)OEM/order-based; not disclosed
BrowbandsDecorative/functional bridle strap across horse's foreheadSame—
Crown piecesBridle headpiece componentsSame—
ReinsLeather (and combination) reinsSame—
Head collars / haltersStable and turnout headwearSame—
Chaps and gaitersRider leg protectionRiders via distributors—
Saddle girthsSaddle-securing strapsEquestrian distributors—
Driving harnessHarness sets for carriage drivingSpecialist driving-sport distributors—
Pony articlesScaled tack for poniesEquestrian distributors—
Horse rugs / coversTurnout and stable rugsEquestrian distributors—
Miscellaneous saddleryOther leather saddlery & harness goodsEquestrian distributors—

Leather Footwear (since FY2008)

ProductDescriptionTarget customer
Formal shoes (men's/women's)Leather dress footwearOverseas brand owners/importers; domestic trade
Riding footwearEquestrian riding boots/shoesEquestrian channel
Deck / marine shoesBoat-shoe styleOverseas importers
Casual shoes; canvas shoesLeisure footwearOverseas/domestic
Countryside bootsOutdoor/country-style boots (relevant to UK market)UK/European importers
Outdoor footwearRugged footwearOverseas importers
Slippers and sandalsOpen footwearDomestic/overseas
Solovair-branded shoes (via JV, planned)Goodyear-welted British heritage footwear from NPS Shoes, to be introduced in India and made/exported via the JVPremium Indian and global consumers

Note: The Solovair introduction was announced in October 2023; actual Indian launch status, volumes and pricing are not publicly disclosed.

Leather Accessories

ProductDescriptionTarget customer
Leather bagsFashion and utility bagsImporters, wholesalers
BeltsMen's/women's leather beltsImporters, wholesalers
WalletsSmall leather goodsImporters, wholesalers

Pet Accessories

ProductDescriptionTarget customer
Dog collarsLeather collarsPet-product importers
LeadsLeather leashesPet-product importers
Dog coversCoats/coversPet-product importers
Dog toysLeather/other toysPet-product importers

Finished Leather (Unnao tannery)

ProductDescriptionTarget customer
Finished leather (all types)Processed from raw hides; for footwear, bags, belts, harnessCaptive use; domestic and export manufacturers
Harness leatherHeavy leathers for saddlery/harnessCaptive; equestrian manufacturers
Upholstery leatherFor furniture/upholsteryUpholstery manufacturers
Bag, belt and footwear leatherCategory-specific finished leathersLeather-goods makers

Chemicals

ProductDescriptionTarget customer
Leather chemicals (trading)Domestic trading in tanning/finishing chemicalsTanneries in the Kanpur–Unnao cluster

Flagship offerings

The company does not designate flagship SKUs. On the basis of heritage and certifications, the equestrian saddlery range and LWG Gold-rated finished leather are its most differentiated offerings; the Solovair partnership is the intended flagship of its branded-footwear ambitions.

Financial Narrative

Basis: Consolidated. FY2022–FY2023 from Screener.in (rounded to INR 1 Cr except where filings give precise values, e.g., FY2023 PAT of INR 1.16 Cr per FY2023 Annual Report). FY2024 from quarterly filings and FY2025 comparatives. FY2025–FY2026 from audited results filed 15 May 2026 and FY2025 Board's Report. Where sources conflict, both are noted.

Income statement

Gross profit: Not publicly disclosed on a consistent basis. An aggregator (Craft) cites Q3 FY2026 gross profit of INR 7.21 Cr on revenue of INR 25.56 Cr (≈28%), which cannot be verified from primary filings.

Revenue CAGR: FY2022–FY2026 ≈ 15.2% (61 → 107.33); FY2023–FY2026 ≈ 15.3%. Screener.in cites 3-year sales CAGR of 15% and TTM growth of 52%.

Commentary — P&L trends and drivers. The defining feature of AKI India's recent P&L is a deterioration in core operating economics masked by rising other income. Operating EBITDA (before other income) fell from a peak of ≈INR 2.9 Cr (4.1% margin) in FY2023 to a loss of INR 3.31 Cr (-3.1%) in FY2026, even as revenue grew 53%. Over the same period other income more than tripled to INR 10.94 Cr — exceeding the entire reported PBT four times over. Every quarter from Q1 FY2026 through Q1 FY2027 except Q2 FY2026 shows negative operating profit (Q3 FY2026 OPM -6.6%, Q4 FY2026 -3.9%). The likely drivers are: (i) pricing pressure in export markets after the US imposed a 50% tariff on Indian goods from 27 August 2025; (ii) a mix shift toward lower-margin traded goods and intra-group sales; (iii) under-absorption at the standalone level, where sales fell; and (iv) cost of scaling the UK subsidiary. The composition of other income is not itemised publicly — if it is dominated by export incentives (e.g., RoDTEP/duty drawback) or forex gains, it is a legitimate part of export economics; if it reflects interest on inter-corporate deposits or one-offs, earnings quality is weaker. Finance costs have been stable at ≈INR 1.8–2.1 Cr.

Quarterly trajectory (consolidated)

Source: Quarterly results via Screener.in; Q1 FY2027 per results filed 11 August 2026 (consolidated revenue INR 29.04 Cr vs INR 17.66 Cr, +64.4% YoY; PAT INR 0.51 Cr vs INR 0.23 Cr; share of profit from associates/JV INR 0.45 Cr vs INR 0.02 Cr).

Q1 FY2027 is notable: consolidated PAT of INR 0.51 Cr included INR 0.45 Cr of associate/JV profit — i.e., nearly 90% of group profit came from equity-accounted earnings. Standalone PAT fell 28.6% YoY to INR 0.15 Cr after an exceptional charge of INR 0.07 Cr, on standalone net sales of INR 18.68 Cr (+64.4% YoY but -13.8% QoQ).

Balance sheet

Notes: Short-term vs. long-term debt split is not publicly disclosed in the sources reviewed; CRISIL's facility list (INR 6 Cr term loan; INR 18.4 Cr packing credit, post-shipment credit, export funding and foreign LC limits; INR 0.1 Cr cash credit) indicates the borrowing base is predominantly short-term export credit. Goodwill & intangibles: not separately disclosed; presumed immaterial. FY2025 standalone current assets are derived (total assets INR 110.09 Cr less non-current assets, approximated); treat as indicative.

Commentary — balance sheet. The balance sheet was transformed by the January 2024 preferential issue and the June 2025 warrant conversion, which lifted consolidated equity from ≈INR 15 Cr (FY2023) to INR 100.3 Cr (FY2026) and cut gearing from ≈2.0x to 0.27x. However, the new capital has been absorbed almost entirely into working capital rather than productive fixed assets: net fixed assets are unchanged at ≈INR 14 Cr over five years, CWIP has crept up to INR 10 Cr (with no disclosed commissioning timeline), and "other assets" (inventories, receivables, loans and advances) have tripled from INR 42 Cr to INR 135 Cr. With borrowings again rising (INR 18 Cr → INR 27 Cr since FY2024), the company is re-leveraging to fund inventory.

Cash flow

Sources: Screener.in consolidated cash flows; FY2026 standalone CFO was -INR 20.26 Cr and standalone financing inflow INR 22.81 Cr (audited results). Capex derived as FCF minus CFO.

Commentary — cash flow. Cumulative free cash flow over FY2024–FY2026 was approximately -INR 49 Cr, against cumulative reported PAT of ≈INR 5 Cr. The company is funding its growth entirely from equity raises and incremental debt. FY2024's investing outflow of INR 18 Cr (versus capex of ≈INR 5 Cr) implies ≈INR 13 Cr of non-capex investing outflows (e.g., loans, deposits or investments) in the year of the preferential issue — the composition is not disclosed in the sources reviewed and warrants scrutiny.

Ratios

Other: Current ratio 3.43 (Upstox, latest); ROIC not separately computable from public data — ROCE used as proxy; net debt/operating EBITDA is not meaningful (negative EBITDA) for FY2025–FY2026. FY2022 ROE/ROA use rounded data and closing balances and should be treated as indicative only.

Commentary — ratios. Returns have collapsed as equity was multiplied six-fold without a commensurate rise in earnings: ROE has fallen from high single digits to ≈2.3%, well below the cost of capital (Screener notes a three-year average ROE of 2.1%). The cash conversion cycle has almost doubled in three years to 214 days, driven by inventory days rising from 129 to 210 and payable days compressing from 136 to 102 — the latter suggesting suppliers have tightened terms or the company is paying faster for raw hides. Interest coverage of ≈2.3x is adequate only because other income is counted; on operating EBITDA alone, coverage is negative.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRelationshipAccountingCountryNotes

AKI India Limited

Parent / listed entity

—

India

Manufacturing (Unnao), corporate office (Kanpur)

AKI UK Limited

Wholly owned subsidiary

Fully consolidated

United Kingdom

UK sales/distribution arm; Q1 FY2027 branch-auditor review reflected group share of total assets of GBP 413,396 and revenue of GBP 256,869

AKI Castil Shoes LLP

Joint venture / associate

Equity method

India (Unnao)

Incorporated 14 Mar 2024; footwear manufacturing/export; stake not disclosed in sources reviewed. Analyst inference: this is the vehicle for the October 2023 NPS Shoes JV (NPS MD Christian Castle; GST records list a partner named Christian James Edward) — unconfirmed by the company

Segment (consolidated revenue from operations, INR Cr)

Segment (consolidated revenue from operations, INR Cr)FY2024FY2025FY2026

Leather & Leather Goods

70.9280.96107.33

Segment Margins & Growth (%) and Revenue by Segment (%)

Segment metricFY2024FY2025FY2026

Segment YoY revenue growth (%)

1.314.232.6

Contribution to total revenue (%)

100100100

Segment pre-tax income, reported consolidated PBT (INR Cr)

1.892.672.71

Segment PBT margin (%)

2.663.302.52

Revenue by entity (INR Cr)

Revenue by entity (INR Cr)FY2025FY2026

Standalone net sales (AKI India Ltd)

68.6664.71

Consolidated revenue from operations

80.96107.33

Implied contribution of subsidiary net of eliminations

12.3042.62

Profit by entity (INR Cr)

Profit by entity (INR Cr)FY2025FY2026

Standalone PAT

1.631.44

Consolidated PAT

1.681.93

Implied non-standalone PAT contribution

0.050.49

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Cr)

617070.9280.96107.33

Operating EBITDA excl. other income (INR Cr)

2.322.872.35-0.15-3.31

Other income (INR Cr)

333.226.5210.94

EBITDA incl. other income (INR Cr)

5.325.875.576.377.63

Depreciation & amortisation (INR Cr)

221.851.812.03

Finance costs (INR Cr)

121.831.892.12

Profit before tax, reported (INR Cr)

221.892.672.71

Net profit after tax (INR Cr)

21.161.371.681.93

EPS basic (INR)

0.250.170.160.190.19

EPS diluted (INR)

0.250.170.160.190.19

Dividend per share (INR)

00000

Margin metric (%)

Margin metric (%)FY2022FY2023FY2024FY2025FY2026

Operating EBITDA margin (%)

3.84.13.31-0.19-3.08

EBITDA margin incl. other income (%)

8.728.397.857.877.11

PBT margin (%)

3.282.862.663.302.52

Net margin (%)

3.281.661.932.081.80

Income Statement and Per-Share Data (Quarterly)

Quarterly metric (INR Cr)Q1FY2026Q2FY2026Q3FY2026Q4FY2026Q1FY2027

Revenue from operations

17.6627.5225.5636.5829.04

Operating profit

-0.670.46-1.69-1.41-0.03

Other income

1.981.403.933.631.73

PBT

0.330.811.211.130.73

Net profit

0.230.621.090.760.51

EPS (INR)

0.020.060.110.070.05

Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (INR Cr)

6063104114.37160.14

Equity share capital (INR Cr)

10131717.7120.64

Other equity / reserves (INR Cr)

424347.4379.68

Total equity (INR Cr)

14156065.14100.32

Total borrowings (INR Cr)

2930182227

Fixed assets, net (INR Cr)

1412131214

Capital work-in-progress (INR Cr)

347910

Investments (INR Cr)

21112

Other assets incl. current assets (INR Cr)

42468393135

Other liabilities (INR Cr)

1719262733

Working capital proxy: other assets less other liabilities (INR Cr)

25275766102

Balance Sheet (FY2025–FY2026)

Liquidity metric (INR Cr)FY2025FY2026

Cash & cash equivalents, consolidated

2.784.69

Net debt (borrowings less cash)

19.2222.31

Standalone cash & cash equivalents

2.361.69

Standalone current assets

85.00101.92

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Cash from operating activities (INR Cr)

12-18-3-16

Capital expenditure (INR Cr)

-1-2-5-2-5

Free cash flow (INR Cr)

00-23-5-21

Cash from investing activities (INR Cr)

-1-1-18-2-5

Cash from financing activities (INR Cr)

0-136523

Dividends paid (INR Cr)

00000

Share buybacks (INR Cr)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

Return on equity (%, avg equity; FY2022 on closing)

14.38.03.652.692.33

Return on assets (%, avg assets; FY2022 on closing)

3.331.891.641.541.41

ROCE (%, Screener; FY2022 computed)

7.08654

Debt to equity (x)

2.072.000.300.340.27

Interest coverage, (PBT+interest)/interest (x)

3.02.02.032.412.28

Asset turnover (x)

1.021.140.850.740.78

Debtor days

106103109129105

Inventory days

132129179170210

Payable days

124118136125102

Cash conversion cycle (days)

114114151173214

Leverage ratio

Leverage ratioFY2025FY2026

Net debt / EBITDA incl. other income (x)

3.022.92

Region (Standalone Revenue, INR Cr) Overview

Region (standalone revenue, INR Cr)FY2025

Export earnings

37.81

Domestic (derived: standalone net sales less exports)

30.85

Export share of standalone net sales (%)

55.1

Region Overview

RegionDirectionEvidence and reasoning

United Kingdom

Growing (inferred)

Consolidated revenue rose 32.6% in FY2026 while standalone fell, implying growth is coming through the UK subsidiary; India–UK CETA in force from 15 July 2026 grants zero-duty access for Indian leather goods and footwear

India (domestic)

Declining/flat (standalone)

Standalone net sales fell from INR 68.66 Cr (FY2025) to INR 64.71 Cr (FY2026); Q3 FY2026 standalone net sales fell to INR 13.30 Cr from INR 21.75 Cr YoY

United States

Headwind (industry)

US 50% tariff effective 27 Aug 2025; CRISIL expected Indian leather-sector revenue to decline 10–12% in FY2026. AKI's direct US exposure: not disclosed

EU, Australia, UAE, South Africa

—

No data

“—” = not publicly disclosed.

Share Price & Returns

PeriodReturnSource / note

Last close

INR 5.81 (16 Oct 2026)

Screener.in

1 month

-0.5%

ScanX

6 months

+13.0%

ScanX

1 year

-31.9%

ScanX (Screener: -31%)

3 years

-29% CAGR (Screener); ≈-53.5% absolute (Anand Rathi, Sep 2026); -39.4% CAGR (IIFL, Aug 2026)

Sources differ by measurement date

5 years

-92.8% absolute (ScanX); -23.6% CAGR (IIFL, Aug 2026); +19% CAGR (Screener)

Major discrepancy — likely due to differing adjustment for the 1:5 split and corporate actions and the SME-era base price; treat with caution

52-week high / low

INR 8.87 / 3.72

Screener.in, Oct 2026

Earlier 52-week high (as of May 2026)

INR 16.05

Choice/Kotak

Trading segment

NSE BE (trade-for-trade, no intraday netting)

Filings reference "Series: BE"

Valuation Multiples

MultipleAKI IndiaBasis

Market capitalisation (INR Cr)

59.96

10.32 Cr shares

Enterprise value (INR Cr)

82.27

Mcap + borrowings INR 27 Cr − cash INR 4.69 Cr (Mar 2026)

P/E (TTM)

19.8–20.1

TTM PAT INR 2.98 Cr (Q2 FY2026–Q1 FY2027)

P/B

0.60

Book value INR 9.72

EV/Sales (TTM)

0.69

TTM revenue INR 118.70 Cr

EV/EBITDA (TTM, incl. other income)

10.3

TTM EBITDA incl. OI ≈INR 8.02 Cr

Dividend yield

0%

No dividends

Peer multiple

Mirza International

—

P/E

≈50.4 (Tickertape; date of snapshot not specified)

—

P/B

≈1.10

—

Dividend History

YearDividend per share (INR)

FY2019–FY2026

0 (no dividend declared since listing)

Credit Ratings

AgencyRatingOutlookDateInstruments

Moody's

Not rated

———

S&P

Not rated

———

Fitch

Not rated

———

CRISIL Ratings

B (long-term) / A4 (short-term), Issuer Not Cooperating

Stable

30 Mar 2026 (also 22 Jan 2025, 30 Nov 2023)

INR 25 Cr bank facilities

Debt Facilities

FacilityAmount (INR Cr)Tenor type

Term loan

6.0

Long-term

Packing credit

6.0

Short-term

Post-shipment credit

6.0

Short-term

Foreign letter of credit

4.0

Short-term (non-fund)

Export funding

2.4

Short-term

Proposed long-term facility

0.5

Long-term

Cash credit

0.1

Short-term

Total

25.0

≈74% short-term

Analyst Conclusions

Management guidance and consensus

No quantitative management guidance; no consensus. The only forward signals are (i) the ≈INR 30 Cr RPT approval with AKI UK for the coming period, indicating management expects UK-routed sales to keep growing; (ii) CWIP of INR 10 Cr awaiting capitalisation; and (iii) industry projections — CLE expects Indian leather and footwear exports to recover to USD 5.5 bn in FY2027, aided by FTAs.

Bull case

  1. UK zero-duty access is a structural tailwind aimed squarely at AKI's model. With CETA in force since 15 July 2026, a UK subsidiary, and a heritage UK footwear partner, AKI is better positioned than most Kanpur micro-caps to capture the UK opportunity; consolidated revenue already grew 32.6% in FY2026 and 64.4% in Q1 FY2027.

  2. Associate earnings are inflecting. Share of profit from AKI Castil Shoes LLP and associates rose from INR 0.02 Cr to INR 0.45 Cr YoY in Q1 FY2027; if sustained, this alone would annualise to ≈INR 1.8 Cr — roughly equal to FY2026 group PAT.

  3. Deep discount to book. At P/B 0.60 and EV/Sales 0.69 with debt/equity of 0.27x, the market is pricing in significant value destruction; any demonstrable return to positive operating margins (FY2023 achieved 4.1%) could re-rate the stock sharply.

Bear case

  1. The core business is loss-making at the operating level and burning cash. Operating EBITDA was -INR 3.31 Cr in FY2026; cumulative FCF over three years is ≈-INR 49 Cr; CCC has risen to 214 days. Reported profits rest on other income (INR 10.94 Cr) whose composition is undisclosed.

  2. Governance and disclosure deficits are severe. CRISIL has classified the company as non-cooperative for three consecutive rating cycles; the independent-director bench was reconstituted three times in six months; a substantial SAST disclosure was filed eight months late; and revenue growth is increasingly routed through related parties, with an unexplained gap between standalone, subsidiary and consolidated revenue.

  3. Value has been diluted, not compounded. Equity rose roughly six-fold after preferential issues while ROE fell to ≈2.3%; the shares are down ≈32% over one year and sharply over five years despite the capital raised.

Key catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhat to watch
Q2 FY2027 resultsNov 2026Operating margin sign; standalone vs consolidated divergence; associate share
FY2026 Annual Report deep-diveAvailable nowOther-income breakdown; AKI UK revenue/assets; AKI Castil stake and financials; contingent liabilities; inventory ageing
Related-party flows with AKI UKOngoing vs ≈INR 30 Cr approvalPricing, receivable days on intra-group sales
Solovair India launch / NPS JV disclosuresUndefinedAny commercial launch, volumes or capital commitments
Credit ratingNext CRISIL review (~2027)Whether company resumes cooperation; any upgrade/withdrawal
Board stabilityOngoingAbsence of further independent-director churn; appointment of a regular chair
Transmission of late WTD's 5.59% stakePendingAny change in promoter-group composition
Exit from NSE BE (trade-for-trade) seriesPeriodic exchange reviewLiquidity improvement
CWIP capitalisationFY2027Capacity addition and its utilisation
US tariff and EU FTA developments2026–2027Sector demand and pricing

Concluding analyst verdict

AKI India Limited is a genuine, three-decade-old leather manufacturer with real assets — an LWG Gold-rated tannery at Unnao, a heritage saddlery franchise, a UK subsidiary and a partnership with a respected British bootmaker — and it now sits in the path of one of the most favourable trade developments its industry has seen: zero-duty access to the UK from July 2026. On the surface, the numbers look like a growth story: consolidated revenue up 53% in three years to INR 107 Cr, Q1 FY2027 revenue up 64%, and a balance sheet de-levered to 0.27x debt/equity after successive equity raises.

Beneath the surface, the evidence is considerably less encouraging. The standalone Indian business shrank in FY2026; group operating EBITDA has been negative for two years; profit exists only because of an undisclosed other-income stream and, increasingly, equity-accounted associate earnings; and the company has burned roughly INR 49 Cr of free cash flow in three years while returns on a six-fold larger equity base have collapsed to ≈2%. The working-capital cycle of 214 days is unsustainable for a company with INR 4.7 Cr of cash. Layered on top are governance signals that institutional investors would treat as disqualifying: a credit-rating agency unable to obtain information for three years running, three board reconstitutions in six months, a materially late insider disclosure, and growth routed through related parties with a consolidation arithmetic that does not reconcile in the public record.

The 0.6x price-to-book multiple reflects these concerns rather than ignoring them. The investment case is therefore binary: it hinges on management demonstrating, through transparent disclosure, that UK- and JV-led growth is converting into positive operating cash flow. Until audited segment-level clarity on AKI UK and AKI Castil Shoes LLP is provided and core margins turn positive, the stock remains a high-risk, low-transparency micro-cap suitable only for speculative capital. Stance: Cautious / Avoid pending disclosure improvement.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenure / notesBackground

Asad Kamal Iraqi

Founder & Chief Executive Officer; promoter

Founder; quoted as Founder & CEO in Oct 2023

Leather industry entrepreneur; detailed CV not disclosed; age not disclosed

Mohammad Ajwad

Managing Director; promoter group

MD as of 2026; chaired the 32nd AGM (23 Sep 2026)

Holds 2.91% after June 2025 warrant conversion (30,00,000 shares); designated partner of AKI Castil Shoes LLP per GST records; brother of Mohammad Asjad and Naba Fatima

Mohammad Asjad

Non-Executive Director; promoter group

—

Brother of MD

Naba Fatima

Additional Non-Executive, Non-Independent Director

From 7 Jul 2026

Business management and leather-goods expertise; sister of MD

Prabodh Sharma

Chief Financial Officer

——

Divya Srivastava

Company Secretary & Compliance Officer

——

Osama Anwar

Promoter (per CRISIL)

——

Sameena (Samina) Asad Iraqi

Whole-Time Director (deceased 30 Dec 2025)

Director from Oct 2002

Held 57,69,782 shares (5.59%)

“—” = not publicly disclosed.

Board of Directors

NameCategoryCommittee roles

Mohammad Ajwad

Managing Director (Executive, Promoter)

Member, Stakeholder Relationship Committee

Mohammad Asjad

Non-Executive, Non-Independent (Promoter group)

—

Naba Fatima

Additional Non-Executive, Non-Independent

—

Abdul Rashid Khan

Additional Non-Executive, Independent

Chair of Audit, Nomination & Remuneration, and Stakeholder Relationship Committees; B.Com, LL.B.; 13+ years in law and finance

Sarika Agarwal

Additional Non-Executive, Independent

Member, Audit; NRC; SRC; B.Com; entrepreneur

Veqarul Amin

Additional Non-Executive, Independent

Member, Audit; NRC; qualified leather technologist with 35+ years' industry experience

Board & Management Changes

Date effectiveAppointmentsResignationsContext

9 Jan 2026

Sarika Agarwal, Abdul Rashid Khan, Veqarul Amin (Independent)

Three existing directors (personal reasons; names not captured in summaries)

Followed death of WTD on 30 Dec 2025

8 Apr 2026

Hardika Ladha (made committee chair), Nandish Shaileshbhai Jani (Independent)

Three independent directors (personal reasons) — understood to be the January appointees

Board reconstituted

7 Jul 2026

Sarika Agarwal, Abdul Rashid Khan, Veqarul Amin (re-appointed as Additional Independent Directors); Naba Fatima (Non-Independent)

Hardika Ladha (personal reasons, insufficient time); Nandish Shaileshbhai Jani

Committees reconstituted again

Directors' Remuneration

DirectorRemuneration disclosed (INR Lakh)Period

Samina Asad Iraqi

9.94

Reporting half-year (H2 FY2026)

Mohammad Ajwad

10.93

Reporting half-year (H2 FY2026)

Mohammad Asjad

5.50

Reporting half-year (H2 FY2026)

Shareholding Trend

Shareholder category (%)Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026

Promoters & promoter group

72.8153.5754.7253.9253.92

Foreign institutional investors

0.003.502.710.000.00

Domestic institutional investors

0.000.000.000.000.00

Public / non-institutional

27.2042.9342.5846.0846.08

Shareholder base

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Jun 2026

Number of shareholders

1504,96712,16414,37815,250

Competitive Landscape

Competitors by Segment

Product lineNamed competitorsNotes

Leather footwear exports (OEM/private label)

Mirza International (Kanpur; brands Thomas Crick, Oaktrak, Off The Hook London); Superhouse Ltd (Kanpur); Tata International (leather division); Farida Group; KH Exports

Mirza and Superhouse are Kanpur peers with far greater scale

Domestic branded footwear

Bata India; Relaxo Footwears; Liberty Shoes; Khadim India; Metro Brands; Campus Activewear

Relevant to any Solovair India launch; scale differential is extreme

Equestrian saddlery & harness

Superhouse Ltd (riding/saddlery division); numerous unlisted Kanpur exporters; global brands such as Weatherbeeta, Shires and Horseware (buyers as much as competitors)

Fragmented; AKI's heritage niche

Finished leather / tanneries

Super Tannery Ltd; Amin Tannery Ltd; Mirza International (tannery); Superhouse (tannery)

Kanpur–Unnao cluster

Leather goods & accessories

Bhartiya International; Zenith Exports; Welterman International; Hidesign (private)

Peer set per ScanX industry list

Global footwear/heritage brands (via NPS)

Dr. Martens (historically linked to the same Northamptonshire bootmaking heritage), Red Wing, Grenson

Competitive reference for Solovair positioning

Peer Comparison FY2026

MetricAKI IndiaMirza InternationalSuperhouse

FY2026 revenue (INR Cr)

107.33 (consolidated)

516.23 (standalone); ≈527 (consolidated)

—

Revenue growth (%)

32.6

-9.4 (standalone)

-12.0 (Q4 YoY)

Profitability

Operating EBITDA margin -3.1%; net margin 1.8%

CRISIL cites weaker-than-expected FY2026 revenue and profitability

Q4 FY2026 net loss INR 1.29 Cr

Export share

≈55% (FY2025 standalone)

≈85% of revenue; UK and US ≈64% (FY2025)

Significant (not quantified)

Credit rating

CRISIL B/Stable/A4 (INC)

CRISIL BBB+/Negative/A2 (downgraded Apr 2026)

—

Recent Developments

Layoffs/hiring, litigation, regulatory actions, guidance revisions:* None disclosed in this period.

Company Snapshot

$12.4M

Revenue

16

Employees

1994

Founded

SWOT Analysis

Strengths

  • Vertical integration with environmental credentials — owned Unnao tannery plus LWG Gold rating and ISO 9001/14001/45001 certifications (company website, 2026).
  • Heritage in a defensible niche — 30+ years in saddlery and harness goods, founded with German technical assistance in 1994 (company history).
  • UK foothold — wholly owned AKI UK Limited; intra-group sales of INR 12.30 Cr in a half-year and a ≈INR 30 Cr RPT envelope approved in Sept 2026.
  • Recapitalised balance sheet — consolidated equity of INR 100.3 Cr (Mar 2026) vs ≈INR 15 Cr (Mar 2023); debt/equity down from ≈2.0x to 0.27x.
  • Top-line momentum at group level — FY2026 consolidated revenue +32.6%; Q1 FY2027 +64.4% YoY.
  • Promoter skin in the game — promoter group retains 53.92%; MD added 30 lakh shares via warrant conversion in June 2025.

Weaknesses

  • Negative core profitability — operating EBITDA of -INR 3.31 Cr (-3.1%) in FY2026; negative operating profit in four of the last five quarters.
  • Earnings dependence on other income and associates — FY2026 other income INR 10.94 Cr vs PBT INR 2.71 Cr; associate share was ≈89% of Q1 FY2027 PAT.
  • Severe working-capital intensity — CCC 214 days, inventory days 210 (FY2026).
  • Persistent cash burn — cumulative FCF ≈ -INR 49 Cr over FY2024–FY2026.
  • Sub-par returns — ROE ≈2.3% (FY2026); three-year average 2.1%.
  • Weak disclosure — CRISIL "Issuer Not Cooperating" since at least 2023; no investor presentations; delayed SAST disclosure (event June 2025, filed Feb 2026).

Opportunities

  • India–UK CETA — zero-duty UK access from 15 Jul 2026; CLE targets USD 1 bn of UK exports in ≈2.5 years.
  • Solovair/NPS partnership — premium branded footwear in a growing Indian lifestyle market; associate earnings already scaling (INR 0.45 Cr in Q1 FY2027).
  • Further FTAs (EU, EFTA, Oman, NZ) — CLE cites these as long-term export catalysts.
  • Budget 2026 input-duty relief — duty-free imports of specified inputs for leather exporters.
  • Industry consolidation/China+1 sourcing — CLE notes growing interest from foreign investors in Indian footwear capacity.
  • Monetising LWG Gold leather — sustainable-leather demand from global brands.

Threats

  • US tariff regime — 50% tariff from Aug 2025; CRISIL forecast 10–12% sector revenue decline in FY2026.
  • Credit constraints — CRISIL B/A4 ratings limit cost and availability of bank credit on INR 25 Cr facilities.
  • Governance perception — three board reconstitutions in six months (Jan, Apr, Jul 2026); NSE BE (trade-for-trade) series reduces liquidity.
  • Related-party concentration — growing share of revenue routed through AKI UK and AKI Castil Shoes LLP; promoter votes invalidated on RPT resolution at 2026 AGM (by law), signalling sensitivity.
  • Larger, better-capitalised competitors — Mirza (INR 516 Cr standalone revenue) and Superhouse in the same cluster.
  • Regulatory/environmental action on Kanpur–Unnao tanneries (industry precedent of closure orders) and hide-price volatility.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
15 May 2025Board records receipt of second-tranche consideration for 1,46,73,782 warrantsProgress on INR 80 Cr programme
24 May 2025Board records receipt of third-tranche considerationConversion readiness
9 Jun 2025Allotment of 1,46,73,782 shares on warrant conversion; paid-up capital to INR 20.64 Cr≈16.6% dilution; equity strengthened
9 Jun 2025MD Mohammad Ajwad acquires 30,00,000 shares via conversion (2.91%) — disclosed under SASTInsider commitment
22 Jul 2025FY2025 results/Board's Report: consolidated revenue INR 80.96 Cr (+14.2%), PBT INR 2.67 Cr (+42%), PAT INR 1.68 Cr (+22.7%); exports INR 37.81 Cr; new statutory and secretarial auditors recommendedBaseline year
13 Aug 202531st AGM (virtual)Routine
14–15 Aug 2025Q1 FY2026: revenue INR 17.66 Cr; PAT INR 0.23 Cr (-46.5% YoY)Weak start
27 Aug 2025US 50% tariff on Indian goods takes effect (industry)Sector headwind
Oct 2025CRISIL forecasts 10–12% decline in Indian leather-sector revenue for FY2026 (industry)Sector headwind
16 Nov 2025Q2 FY2026: total income INR 28.93 Cr (+99.7% YoY); PAT INR 0.62 Cr (+59% YoY)Consolidation-driven growth
30 Dec 2025Death of WTD Sameena Asad Iraqi (5.59% holder; director since 2002)Leadership loss; promoter-group holding transmission pending
9 Jan 2026Three independent directors appointed; three resign; committees reconstitutedGovernance churn begins
1 Feb 2026Union Budget proposes duty-free import of specified inputs for leather exporters and extends export-obligation period to one year (industry)Sector tailwind
12 Feb 2026Q3 FY2026: consolidated revenue INR 25.56 Cr, PAT INR 1.09 Cr (+51% YoY); standalone net sales down to INR 13.30 Cr from INR 21.75 Cr; standalone PAT INR 0.19 Cr vs INR 0.67 CrDivergence of standalone vs consolidated
23 Feb 2026SAST disclosure filed for Mohammad Ajwad's June 2025 acquisitionDelayed disclosure (≈8 months after event) — compliance observation
27 Mar 2026Shares hit 52-week low of INR 4.01; down ≈52% YoYMarket de-rating
30 Mar 2026CRISIL reaffirms B/Stable/A4 "Issuer Not Cooperating"Credit/disclosure red flag
8 Apr 2026Board reconstituted again (Ladha, Jani appointed; three IDs resign)Governance churn
15 May 2026FY2026 audited results: consolidated revenue INR 107.33 Cr (+32.6%), PAT INR 1.93 Cr (+15.3%); standalone PAT INR 1.44 Cr (-11.7%); unmodified audit opinion; internal auditor appointedFull-year outcome
20 Jun 2026Audit report resubmitted in SEBI-prescribed format at exchange instruction (no change in numbers)Procedural compliance
7 Jul 2026Four directors appointed (three IDs + Naba Fatima); Hardika Ladha and Nandish Jani resignThird reconstitution in six months
15 Jul 2026India–UK CETA enters into force; zero-duty access for Indian leather and footwear in UK (industry)Key tailwind for UK-oriented strategy
11 Aug 2026Q1 FY2027: consolidated revenue INR 29.04 Cr (+64.4% YoY), PAT INR 0.51 Cr (+121%); associate share INR 0.45 Cr; standalone PAT INR 0.15 Cr (-28.6%) after exceptional itemProfit increasingly from associates
1 Sep 2026Board approves material RPTs with AKI UK (≈INR 30 Cr) subject to AGM approval; FY2026 Annual Report and AGM notice approvedRPT scale rising
2 Sep 2026Book closure 16–23 Sep announced; stock leads BSE "B" group gainers; shares rise ≈74% over four sessions, hitting 10% upper circuitsSpeculative price action
3 Sep 2026S A Capitals buys 5.5 lakh shares at INR 6.57Bulk-deal activity
7 Sep 2026Company clarifies to exchanges that price movement was not driven by undisclosed informationExchange surveillance response
22–28 Sep 2026Alternating upper and lower circuits (±5% band)Illiquid, volatile trading
23 Sep 202632nd AGM (VC/OAVM), chaired by MDAnnual approvals
25 Sep 2026Scrutiniser's report: all seven resolutions passed; 60,431,623 votes polled (58.55% of shares); promoter-group votes invalidated on RPT resolution (as required by law)RPT approved by non-interested shareholders
30 Sep 2026Trading window closed from 1 Oct 2026 until 48 hours after Q2 FY2027 resultsQ2 results expected Nov 2026
14 Oct 2026Regulation 74(5) certificate filed for quarter ended 30 Sep 2026Routine

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Revenue by Entity: Standalone net sales (AKI India Ltd) fell from INR 686.6 Mn in FY2025 to INR 647.1 Mn in FY2026.
AKI India Limited — Revenue by Entity
Series (INR Mn)FY2025FY2026
Standalone net sales (AKI India Ltd)686.6647.1
Consolidated revenue from operations809.61,073.3
Implied contribution of subsidiary net of eliminations123426.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. AKI India Limited — company website: About Us, product categories, contacts (groupaki.com, accessed Oct 2026)
  2. NSE/BSE filings: Board outcome 15 May 2025; 24 May 2025; 9 Jun 2025 (warrant conversion) · Q3 FY2026 results 12 Feb 2026 · FY2026 audited results 15 May 2026 · Q1 FY2027 results 11 Aug 2026 · JV disclosure with NPS Shoes (Oct 2023); in-principle approval for warrants; board-meeting intimation 25 May 2022
  3. CRISIL Ratings — AKI India Limited rating rationales: 30 Mar 2026; 22 Jan 2025; 30 Nov 2023; 29 Sep 2022 (business overview)
  4. CRISIL Ratings — Mirza International rating rationale, 8 Apr 2026
  5. Mirza International — FY2026 audited results, 29 May 2026 (NSE)
  6. Screener.in — AKI India consolidated financials, shareholding, ratios, announcements (aggregator: Oct 2026)
  7. ScanX/Dhan — summaries of FY2025 Board's Report (22 Jul 2025), board changes (Jan/Apr/Jul 2026), FY2026 results (May/Jun 2026), Q1 FY2027 results (Aug 2026), AGM scrutiniser report (Sep 2026) (aggregator)
  8. Kotak Neo / Kotak Securities — quarterly result summaries Q3 FY2025 to Q4 FY2026 (aggregator)
  9. MarketScreener — news register and director list (aggregator)
  10. Groww, Tickertape, HDFC Securities, Chola Securities, Stockfin — 2026 newsflow summaries (aggregators)
  11. Chittorgarh: HDFC Securities · JK BFSL — SME IPO details (2018)
  12. InstaFinancials (MCA data) — CIN, incorporation, capital
  13. Arihant Capital / CMOTS: IIFL — company background, auditor, registrar, history
  14. Paperli (MCA) and Pice (GST) — AKI Castil Shoes LLP incorporation and registration details
  15. IANS: India Retailing · Goodreturns · CB Insights — NPS Shoes JV and INR 80 Cr fundraise (Oct 2023)
  16. Morningstar: Craft — company profile, employees, executives (aggregators)
  17. Market data: Anand Rathi, IIFL, Upstox, Choice, ICICI Direct, Share.Market, Kotak Neo, ScanX (various dates 2026)
  18. Industry: APLF/Leathernews (Jun 2026) · Council for Leather Exports, "Indian Leather Industry 2026" · Outlook Business/PTI (CLE Chairman, 2026) · Business Standard/PTI (CRISIL sector outlook, Oct 2025 · Budget 2026)
  19. MarketsMojo — 52-week low (27 Mar 2026), Superhouse Q4 FY2026 analysis, stock ratings (Sep 2026)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.